A Brief History of Breast Cancer Awareness Month

National Breast Cancer Awareness Month (NBCAM): The month of October, designated to be an observed commemorative month to raise awareness of breast cancer. Established in 1985 as a partnership between the American Cancer Society and the pharmaceutical division of Imperial Chemical Industries (now part of AstraZeneca, a leading manufacturer of oncology drugs).

See . . . → Read More: A Brief History of Breast Cancer Awareness Month

The Lown Institute's RightCare Alliance

The Lown Institute’s RightCare Alliance is a grassroots movement of clinicians, patients, and community leaders who are demanding and creating change to the healthcare industry — one that sees patients as people, not profits, and gives everyone access not just to care but to the RIGHT CARE for their medical needs.

Learn more: www.rightcarealliance.org . . . → Read More: The Lown Institute’s RightCare Alliance

Even Insured Can Face Crushing Medical Debt, Study Finds

“Even Insured Can Face Crushing Medical Debt, Study Finds,” The New York Times, Jan. 5, 2016.

The number of uninsured Americans has fallen by an estimated 15 million since 2013, thanks largely to the Affordable Care Act. But a new survey, the first detailed study of Americans struggling with medical bills, shows that insurance often . . . → Read More: Even Insured Can Face Crushing Medical Debt, Study Finds

Drug Prices Soar, Prompting Calls for Justification

“Drug Prices Soar, Prompting Calls for Justification,” by Andrew Pollack, The New York Times.

Prices for cancer drugs, some of which extend lives by only a couple of months, routinely exceed $100,000 a year, and some new ones exceed $150,000. And it is not unusual for the list prices of existing drugs to rise 10 . . . → Read More: Drug Prices Soar, Prompting Calls for Justification

Pharmascolds Are Not Worse Than The Pervasive Conflicts Of Interest They Criticize

“Pharmascolds Are Not Worse Than The Pervasive Conflicts Of Interest They Criticize,” by Larry Huston, Forbes.

Let’s start with a quick poll:

Which is worse?

A. The pervasive influence of industry on medicine, which has undermined the independence and altruism of physicians. B. The critics of industry influence, who have created a paranoid culture . . . → Read More: Pharmascolds are not worse than the pervasive conflicts of interest, they criticize

The Importance of Getting Sick in the Right Place

“The Importance of Getting Sick in the Right Place” by Abigail Zuger MD, The New York Times.

It is increasingly critical for patients to be sick in the right place, and increasingly difficult for them to do so. As the great plates of medical care heave and split in cash-based tectonics, the options are multiplying . . . → Read More: The Importance of Getting Sick in the Right Place

Marketing to Doctors

“Marketing to Doctors,” John Oliver, Last Week Tonight with John Oliver.

This eye-opening video reveals how pharmaceutical companies spend billions of dollars every year marketing drugs to you and your doctors.

A study in 2013 found that 9 out of 10 of the top ten drug manufacturers spent more on marketing than they did . . . → Read More: Marketing to Doctors

Why Drugs Cost So Much

“Why Drugs Cost So Much,” Peter Bach, The New York Times.

ELI LILLY charges more than $13,000 a month for Cyramza, the newest drug to treat stomach cancer. The latest medicine for lung cancer, Novartis’s Zykadia, costs almost $14,000 a month. Amgen’s Blincyto, for leukemia, will cost $64,000 a month. Cyramza costs the average . . . → Read More: Why Drugs Cost So Much

Courageous Nonprofit Leadership Groups Greatly Needed

“Courageous Nonprofit Leadership Groups Are Greatly Needed,” Pablo Eisenberg, Chronicle of Philanthropy.

As the government has shrunk its role, the public expects more of nonprofits, but such groups can’t shoulder that burden unless they have more dollars at their disposal.

Most grant makers don’t give more than the 5 percent of assets that is the . . . → Read More: Courageous Nonprofit Leadership Groups Greatly Needed

Infographic Shows The Differences Between The Diseases We Donate To, And The Diseases That Kill Us

“Infographic Shows The Differences Between The Diseases We Donate To, And The Diseases That Kill Us.” By Stephen Luntz, IFL Science.

For an article in Vox Julia Belluz created an infographic using figures from the Centers for Disease Control for 2011 to compare how much money is donated to fight various diseases and how many . . . → Read More: Infographic Shows The Differences Between The Diseases We Donate To, And The Diseases That Kill Us

Articles & Posts